Oaktree Fund Advisors »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Oaktree Fund Advisors

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Oaktree Fund Advisors from 13F filings

Historical chart of Oaktree Fund Advisors investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Oaktree Fund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Oaktree Fund Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $30k 26k 1.14
2024-06-30 $14k 11k 1.29

More positions owned by Oaktree Fund Advisors

Ishares Msci India Etf Etf (INDA)
Anglogold Ashanti Common Stock (AU)
Freeport-mcmoran Common Stock (FCX)
Jd.com Common Stock (JD)
Vale Sa Common Stock (VALE)
Hdfc Bank Common Stock (HDB)
Itau Unibanco Holding Sa Common Stock (ITUB)
Petroleo Brasileiro Sa Common Stock (PBR)
Trip.com Group Common Stock (TCOM)
Yum China Holdings Common Stock (YUMC)
H World Group Common Stock (HTHT)
Infosys Common Stock (INFY)
Pdd Holdings Common Stock (PDD)
Banco Bradesco Sa Common Stock (BBD)
Kanzhun Common Stock (BZ)

View all positions for Oaktree Fund Advisors

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Ing Investment Management
Highbridge Capital Management
Calamos Advisors
Tenor Capital Management
Davidson Kempner Capital Management
Advent Capital Management
Steelhead Partners
Lazard Asset Management
BlackRock
Magnetar Financial
State Street Corporation
OZ Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Lord, Abbett & Co
Bnp Paribas Arbitrage, Snc

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1